275 related articles for article (PubMed ID: 7449338)
21. [Antibody therapy in hematology and oncology--2].
Kneba M; Schrader C; Köhne H
Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
[No Abstract] [Full Text] [Related]
22. [Cellular biology and antitumoral chemotherapy].
Lanza I
Minerva Pediatr; 1968 Jun; 20(24):1233-9. PubMed ID: 5736916
[No Abstract] [Full Text] [Related]
23. [Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy].
Grignani F; Martelli M; Tonato M
Clin Ter; 1974 Mar; 69(3):263-79. PubMed ID: 4846658
[No Abstract] [Full Text] [Related]
24. Sensitivity of normal and neoplastic cells to chemotherapeutic agents in vitro.
Dow LW
Adv Intern Med; 1980; 25():427-52. PubMed ID: 6987848
[No Abstract] [Full Text] [Related]
25. Cancer chemotherapy: a guide for nurses.
Thomson L
Nurs Times; 1979 Jun; 75(25):suppl 1-4. PubMed ID: 255990
[No Abstract] [Full Text] [Related]
26. The heterogeneous proliferation of human cancer cells in vivo.
Post J; Sklarew RJ
Pathol Annu; 1985; 20 Pt 1():359-81. PubMed ID: 3887298
[No Abstract] [Full Text] [Related]
27. Review: potential role of cell cycle synchronizing agents in combination treatment modalities of malignant tumors.
Zalatnai A
In Vivo; 2005; 19(1):85-91. PubMed ID: 15796159
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapeutics of malignant tumor proliferation. II. Biochemical aspects of the effect of cytostatics].
Semonský M; Veselý J; Semonská S
Cesk Farm; 1978 Nov; 27(9):395-402. PubMed ID: 747843
[No Abstract] [Full Text] [Related]
29. Therapeutic implications of the new biology.
DeVita VT; Abou-Alfa GK
Cancer J; 2000 Apr; 6 Suppl 2():S113-20. PubMed ID: 10803824
[No Abstract] [Full Text] [Related]
30. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants.
Zatsepina OV; Todorov IT; Philipova RN; Krachmarov CP; Trendelenburg MF; Jordan EG
Eur J Cell Biol; 1997 May; 73(1):58-70. PubMed ID: 9174672
[TBL] [Abstract][Full Text] [Related]
31. [The action of antimitotics and the cell cycle].
Deysson G
Bull Assoc Anat (Nancy); 1979 Mar; 63(180):83-107. PubMed ID: 393327
[TBL] [Abstract][Full Text] [Related]
32. [Antimitotic chemotherapy and proliferative activity of leukemic cells].
Astaldi G; Meardi G
Minerva Med; 1966 Mar; 57(25):1094-6. PubMed ID: 5932009
[No Abstract] [Full Text] [Related]
33. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy and proliferative potentiality of the leukemic elements].
Dogliotti GC; Pileri A
Minerva Med; 1966 Mar; 57(25):1086-90. PubMed ID: 5932007
[No Abstract] [Full Text] [Related]
35. Need for new approach to chemotherapy of cancer.
Korgaonkar KS
Panminerva Med; 1976; 18(3-4):121-4. PubMed ID: 1256901
[No Abstract] [Full Text] [Related]
36. The Myc oncoprotein as a therapeutic target for human cancer.
Vita M; Henriksson M
Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
[TBL] [Abstract][Full Text] [Related]
37. [Cell differentiation induction therapy in leukemia].
Tashima M; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Izumi Y; Uchino H
Nihon Rinsho; 1986 Feb; 44(2):388-94. PubMed ID: 3517417
[No Abstract] [Full Text] [Related]
38. [Progress in chemotherapy of hemoblastoses: synchronization of the cellular cycle].
Geib KR
Med Interna (Bucur); 1972 Oct; 24(10):1169-74. PubMed ID: 4650746
[No Abstract] [Full Text] [Related]
39. Growth kinetics of minimal tumour masses: implications for rational chemotherapy.
Pileri A; Boccadoro M; Mandelli F; Amadori S
Haematologica; 1981 Oct; 66(5):545-53. PubMed ID: 6796464
[No Abstract] [Full Text] [Related]
40. [Clinical studies on combined chemotherapy of leukemia with partial cell synchronization].
Büchner T; Asseburg U; Kamanabroo D; Hiddemann W; Hiddemann RM; Barlogie B; Göhde W
Verh Dtsch Ges Inn Med; 1974; 80():1674-8. PubMed ID: 4532883
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
